![Mark Collins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Collins
Direktor/Vorstandsmitglied bei
LUNAI BIOWORKS INC.
Vermögen: 18 748 $ am 30.09.2026
Profil
Dr. Mark A. Collins is an Independent Director at Lunai Bioworks, Inc. and a Chief Scientific Officer at Undaunted Bio, Inc. He is on the Board of Directors at Lunai Bioworks, Inc. Dr. Collins was previously employed as a Chief Technology Officer by Helomics Corp.
and a Vice President-Translational Service by icometrix NV.
He received his undergraduate degree from the University of Wolverhampton and a doctorate degree from the University of Surrey.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LUNAI BIOWORKS, INC. 0,25 % | 13.10.2026 | 12 754 ( 0,25 % ) | 18 748 $ | 30.09.2026 |
Aktive Positionen von Mark Collins
| Unternehmen | Position | Beginn |
|---|---|---|
| LUNAI BIOWORKS INC. | Direktor/Vorstandsmitglied | 14.10.2024 |
Ehemalige bekannte Positionen von Mark Collins
| Unternehmen | Position | Ende |
|---|---|---|
Helomics Corp.
 Helomics Corp. Miscellaneous Commercial ServicesCommercial Services Provides cancer care development and treatment consulting services | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
icometrix NV
 icometrix NV Packaged SoftwareTechnology Services Provides AI-powered brain imaging analysis for neurological disorders | Corporate Officer/Principal | 01.01.2021 |
Ausbildung von Mark Collins
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
13
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Lunai Bioworks, Inc.
 Lunai Bioworks, Inc. BiotechnologyHealth Technology Operates as preclinical stage biotechnology company developing technologies and therapies for HIV, HBV and cancer | Health Technology |
Helomics Corp.
Helomics Corp. Miscellaneous Commercial ServicesCommercial Services Provides cancer care development and treatment consulting services | Commercial Services |
University of Wolverhampton
 University of Wolverhampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Surrey
 University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
icometrix NV
icometrix NV Packaged SoftwareTechnology Services Provides AI-powered brain imaging analysis for neurological disorders | Technology Services |
